Paras Healthcare shares made their stock market debut on October 28, 2026, listing at ₹715 per share against the IPO issue price of ₹693. The listing price represented a premium of 3.17%, giving the hospital operator a market capitalisation of approximately ₹7,760 crore.
The company’s stock market entry comes at a time when investors are closely tracking India’s growing healthcare industry. Paras Healthcare operates a network of hospitals across multiple cities, providing specialised medical services.
However, the listing premium is only one part of the company’s market performance. Its financial results, profitability, debt levels and valuation will also remain important factors as the company begins trading on the stock exchanges.
Paras Healthcare IPO Listing: Key Details
| Particulars | Details |
|---|---|
| Listing date | October 28, 2026 |
| IPO issue price | ₹693 per share |
| Listing price | ₹715 per share |
| Listing premium | 3.17% |
| Market capitalisation at listing | Approximately ₹7,760 crore |
| Post-listing P/E ratio | Approximately 177 times |
| FY26 operating revenue | ₹1,605.95 crore |
| FY26 net profit | ₹43.83 crore |
The shares listed above the issue price, although the premium was relatively modest. The company’s subsequent performance will depend on market demand and how investors assess its financial performance and valuation.
Paras Healthcare IPO: How Much Did Investors Gain?
Investors who received shares in the IPO saw an increase in the value of their holdings at the reported listing price.
The issue price was ₹693 per share, while the listing price was ₹715. This resulted in a difference of ₹22 per share.
| Calculation | Amount |
|---|---|
| IPO issue price | ₹693 |
| Listing price | ₹715 |
| Gain per share | ₹22 |
| Listing return | 3.17% |
The calculation is based on the issue and listing prices. Actual returns depend on the execution price and applicable transaction charges.
Paras Healthcare Financial Performance in FY26
Paras Healthcare reported operating revenue of ₹1,605.95 crore in FY26, alongside EBITDA of ₹335.58 crore. Its EBITDA margin stood at 20.60%, reflecting the operating earnings generated from its hospital business before interest, taxes, depreciation and amortisation.
The company also reported a net profit of ₹43.83 crore after recording losses in previous financial years, according to the supplied financial information.
Paras Healthcare FY26 Financial Snapshot
| Financial indicator | FY26 figure |
|---|---|
| Operating revenue | ₹1,605.95 crore |
| EBITDA | ₹335.58 crore |
| EBITDA margin | 20.60% |
| Net profit | ₹43.83 crore |
| Net profit margin | Approximately 2.73% |
The difference between EBITDA and net profit is an important aspect of the company’s financial performance. Although operating earnings were higher, the final profit available after expenses remained relatively small compared with total revenue.
Interest costs, depreciation and other expenses can influence the amount of operating earnings that ultimately translates into net profit. The company’s ability to improve this conversion will be an important financial indicator in future quarters.
Why Is Paras Healthcare’s Valuation in Focus?
At the reported listing price of ₹715, Paras Healthcare’s post-listing price-to-earnings ratio stood at approximately 177 times.
The P/E ratio compares a company’s share price with its earnings per share. A higher ratio means investors are paying more for each unit of reported earnings.
In Paras Healthcare’s case, the valuation needs to be considered alongside its growth potential, profitability and capital requirements.
The company operates in an industry where demand for specialised treatment and hospital services can support expansion. However, building new facilities, increasing bed capacity and investing in medical equipment require substantial capital.
The valuation will therefore depend partly on whether revenue growth can translate into stronger net profits over time.
Paras Healthcare’s Hospital Network and Expansion
The company’s hospital network is a key part of its business. According to the supplied information, Paras Healthcare operated eight hospitals with a total capacity of 2,211 beds as of June 30, 2026.
Hospital performance depends on several operating factors, including patient occupancy, treatment mix, revenue per occupied bed and the efficient use of medical infrastructure.
Expansion can create opportunities to serve more patients and increase revenue. However, new hospitals and additional capacity may also involve higher operating costs and capital expenditure before they reach their expected level of activity.
For this reason, investors tracking the company’s performance will need to consider both the pace of expansion and the financial returns generated by its hospital network.
Paras Healthcare IPO: Debt and Profitability
Debt is another important factor in evaluating the company’s financial position.
The IPO included a fresh issue of shares, with part of the proceeds intended for repayment of borrowings. Reducing debt can potentially lower interest expenses and improve net profitability, depending on the amount repaid and the company’s subsequent financing requirements.
The effect on future earnings will depend on the company’s borrowing costs, operating cash flow and capital expenditure.
Investors will also be able to assess whether improvements in operating performance are reflected in higher net profit and stronger cash generation.
What Will Matter for Paras Healthcare Shares After Listing?
Following its market debut, the company’s financial performance will remain central to how the market values its shares.
Key factors include:
- Revenue growth: Whether the company continues to increase income from hospital operations.
- Operating margins: Whether EBITDA margins remain stable or improve as business activity expands.
- Net profit: Whether operating earnings translate into sustained growth in the final profit figure.
- Hospital occupancy: Whether existing facilities generate sufficient patient activity and revenue.
- Debt reduction: Whether lower borrowings help reduce interest expenses.
- Cash flow: Whether the business generates enough cash to support operations and expansion.
- Valuation: Whether future earnings growth supports the market price.
These indicators will provide a clearer picture of the company’s financial progress beyond its initial listing performance.
Conclusion
Paras Healthcare listed at ₹715 on October 28, 2026, delivering a 3.17% premium over its IPO issue price of ₹693. The listing valued the hospital operator at approximately ₹7,760 crore.
The company reported FY26 operating revenue of ₹1,605.95 crore and net profit of ₹43.83 crore, alongside an EBITDA margin of 20.60%. Its hospital network and expansion plans form an important part of its business profile.
At the same time, the reported post-listing P/E ratio of approximately 177 times and the relatively low net profit margin put greater emphasis on future earnings growth and financial efficiency.
The company’s subsequent performance will depend on its ability to grow revenue, manage expenses, improve profitability and maintain a sustainable financial position.
Read Also : IREDA vs Inox Wind: Renewable Energy Stocks Fall Up to 7% After Q4 Results
Disclaimer: This article is for informational and educational purposes only. It does not constitute investment advice or a recommendation to buy, sell or hold any security. Financial figures are based on the information provided and should be verified against official company disclosures.
